Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › French Camp › NPI 1801830583
Hospital

County of San Joaquin

County of San Joaquin was paid $11.15M by Medicaid between Jan 2018 and Nov 2024, across 275 billing codes. Its largest line is 0450, Emergency room services — 14% of everything it billed.

33Billing provider infoCOUNTY OF SAN JOAQUIN
FRENCH CAMP, CA 95231
33aNPI1801830583assigned 06/15/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.15M
24GClaims339,113
24DCodes billed275
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#170 of 410
Median peer was paid$6.90M
This provider vs. median1.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201818,087$411K
201929,361$578K
202024,002$578K
202130,768$793K
202236,292$952K
202346,453$1.13M
2024incomplete154,150$6.70M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 14% 25,797 22,956 $1.56M
90999 Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient 7.8% 5,455 451 $871K
0682 4.6% 128 128 $512K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 4.1% 2,461 2,406 $452K
J0882 Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) 3.7% 999 272 $414K
0510 3.6% 12,267 10,788 $403K
J0606 Injection, etelcalcetide, 0.1 mg 3.3% 971 79 $367K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.1% 1,691 1,385 $343K
70450 Computed tomography, head or brain; without contrast material 2.9% 2,844 2,436 $324K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 3,766 3,499 $250K
80053 Comprehensive metabolic panel 2.0% 19,045 17,565 $226K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.8% 7,821 7,250 $205K
263 more codes
0762 1.8% 372 $205K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 2,565 $203K
72125 Computed tomography, cervical spine; without contrast material 1.8% 1,194 $198K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.7% 3,404 $194K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.7% 21,084 $186K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.4% 2,098 $160K
0760 1.2% 12,561 $137K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.2% 1,751 $131K
96361 Intravenous infusion, hydration; each additional hour 1.0% 2,569 $115K
96375 Therapeutic injection; each additional sequential IV push 1.0% 2,815 $115K
71045 Radiologic examination, chest; single view <1% 11,045 $100K
0270 <1% 15,923 $99K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,397 $96K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 2,038 $94K
99284 Emergency room visit (serious) <1% 1,115 $88K
0250 <1% 13,884 $86K
77067 Screening mammography, bilateral, including computer-aided detection <1% 803 $86K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,087 $77K
J3490 Unclassified drugs <1% 6,787 $75K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,423 $75K
71046 Radiologic examination, chest; 2 views <1% 3,435 $72K
83880 <1% 1,997 $69K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 335 $69K
84443 Thyroid stimulating hormone (TSH) <1% 4,482 $69K
0360 <1% 1,027 $66K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,094 $66K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,286 $65K
84484 <1% 5,069 $64K
G0378 Hospital observation service, per hour <1% 353 $64K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 406 $61K
J1644 Injection, heparin sodium, per 1000 units <1% 1,931 $46K
99199 Unlisted special service, procedure or report <1% 824 $42K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 272 $41K
0750 <1% 309 $41K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,038 $39K
81001 <1% 9,131 $37K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,434 $36K
71250 <1% 240 $34K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 552 $33K
86141 <1% 2,496 $31K
83690 <1% 3,429 $30K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,126 $30K
99214 Doctor's office visit, returning patient (more involved) <1% 1,803 $29K
73130 <1% 1,132 $29K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 487 $29K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,194 $28K
87088 <1% 3,545 $28K
70486 <1% 206 $28K
70498 <1% 169 $28K
80061 Lipid panel <1% 3,333 $27K
72170 <1% 1,266 $27K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 325 $27K
83735 <1% 3,126 $27K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 567 $26K
J1756 Injection, iron sucrose, 1 mg <1% 245 $26K
83605 <1% 1,551 $24K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 460 $24K
73610 <1% 963 $24K
85610 <1% 5,284 $24K
86780 <1% 1,365 $23K
83036 Hemoglobin; glycosylated (A1C) <1% 3,655 $23K
93970 <1% 131 $23K
86803 <1% 1,831 $21K
77063 Screening digital breast tomosynthesis, bilateral <1% 788 $21K
92557 <1% 231 $21K
0761 <1% 1,773 $20K
93971 <1% 184 $19K
76801 <1% 296 $19K
73630 <1% 783 $18K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 68 $18K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 106 $18K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,694 $18K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,526 $18K
90715 <1% 351 $18K
84702 <1% 1,221 $18K
92588 <1% 357 $17K
73110 <1% 713 $17K
76830 Ultrasound, transvaginal <1% 270 $17K
0710 <1% 603 $17K
85730 <1% 2,375 $17K
86703 <1% 1,647 $16K
82948 <1% 2,092 $16K
87040 <1% 670 $16K
81025 <1% 2,957 $16K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 323 $15K
86481 <1% 256 $15K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 190 $13K
80143 <1% 569 $13K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 167 $13K
73560 <1% 723 $12K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 441 $12K
87070 <1% 1,127 $12K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 61 $12K
94729 <1% 266 $11K
80048 Basic metabolic panel (calcium, ionized) <1% 1,226 $11K
90675 <1% 27 $11K
73030 <1% 433 $11K
71271 <1% 99 $11K
94726 <1% 262 $10K
87340 <1% 1,211 $10K
74018 <1% 476 $10K
82728 <1% 865 $10K
84439 <1% 1,195 $10K
76770 <1% 127 $10K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 739 $9K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 194 $9K
92550 <1% 388 $9K
59025 Fetal non-stress test <1% 360 $9K
86850 <1% 1,627 $9K
J2270 Injection, morphine sulfate, up to 10 mg <1% 935 $9K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 105 $9K
76641 <1% 110 $9K
82077 <1% 433 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 343 $8K
84145 <1% 286 $8K
97750 <1% 202 $8K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 197 $7K
99213 Doctor's office visit, returning patient (routine) <1% 534 $7K
82607 <1% 714 $7K
86706 <1% 761 $7K
86901 <1% 1,664 $7K
94060 <1% 236 $7K
80069 <1% 943 $7K
86160 <1% 317 $7K
72131 <1% 46 $6K
83970 <1% 165 $6K
85651 <1% 2,088 $6K
87634 <1% 80 $6K
0160 <1% 79 $6K
73070 <1% 275 $6K
85027 <1% 1,017 $6K
86900 <1% 1,674 $6K
86704 <1% 481 $6K
96367 <1% 123 $5K
73090 <1% 254 $5K
73562 <1% 266 $5K
73590 <1% 242 $5K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 729 $5K
83550 <1% 760 $5K
76536 <1% 80 $5K
87632 <1% 30 $5K
72100 <1% 165 $5K
80076 <1% 589 $5K
77066 Tomosynthesis, mammo <1% 31 $5K
86225 <1% 375 $4K
87186 <1% 410 $4K
82550 <1% 502 $4K
73552 <1% 113 $4K
J1453 Injection, fosaprepitant, 1 mg <1% 52 $4K
87077 <1% 485 $4K
86705 <1% 333 $4K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 87 $4K
80179 <1% 195 $4K
73502 <1% 111 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 36 $4K
99070 <1% 592 $3K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 190 $3K
0324 <1% 60 $3K
93000 <1% 80 $3K
93308 <1% 33 $3K
73140 <1% 210 $3K
95811 <1% 12 $3K
99000 <1% 935 $3K
82565 <1% 605 $3K
76870 <1% 70 $3K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 76 $3K
J2469 Injection, palonosetron hcl, 25 mcg <1% 61 $3K
84100 <1% 522 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,360 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 91 $3K
85379 <1% 191 $3K
94664 <1% 231 $2K
93793 <1% 886 $2K
74022 <1% 67 $2K
82803 <1% 85 $2K
69210 <1% 72 $2K
72040 <1% 75 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 115 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 389 $2K
20610 <1% 88 $2K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 27 $2K
82746 <1% 146 $2K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 148 $2K
84520 <1% 472 $2K
77080 <1% 54 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 250 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 65 $2K
90686 <1% 54 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 50 $1K
71020 <1% 46 $1K
J2704 Injection, propofol, 10 mg <1% 279 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 40 $1K
94618 <1% 109 $1K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 30 $1K
82043 <1% 359 $1K
73060 <1% 65 $1K
86038 <1% 125 $1K
J1953 Injection, levetiracetam, 10 mg <1% 34 $1K
0636 <1% 150 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 74 $1K
81002 <1% 491 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 141 $1K
83721 <1% 173 $975.46
99499 <1% 30 $942.40
J1815 Injection, insulin, per 5 units <1% 124 $940.41
36000 <1% 58 $923.58
93017 <1% 15 $908.78
86235 <1% 65 $836.96
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 99 $834.52
73020 <1% 29 $799.59
87210 <1% 143 $729.36
72110 <1% 16 $701.70
99203 Doctor's office visit, new patient (routine) <1% 13 $695.13
82805 <1% 13 $689.80
A4649 Surgical supply; miscellaneous <1% 91 $678.70
93242 <1% 42 $653.04
82553 <1% 52 $625.92
76881 <1% 15 $611.16
Q3014 Telehealth originating site facility fee <1% 42 $607.36
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 29 $590.97
86430 <1% 91 $575.51
73521 <1% 18 $556.53
84550 <1% 116 $541.17
99244 Office or other outpatient consultation, moderate to high complexity <1% 26 $519.44
86255 <1% 40 $509.27
82009 <1% 92 $488.34
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 118 $449.06
81015 <1% 127 $418.19
93246 <1% 25 $370.50
J8540 Dexamethasone, oral, 0.25 mg <1% 16 $353.26
90656 <1% 14 $331.65
92587 <1% 13 $328.00
87147 <1% 68 $321.29
29700 <1% 16 $281.51
82150 <1% 45 $280.91
0700 <1% 16 $280.24
J2060 Injection, lorazepam, 2 mg <1% 27 $271.18
82140 <1% 15 $268.90
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 14 $267.58
72200 <1% 12 $264.84
J1790 Injection, droperidol, up to 5 mg <1% 14 $258.71
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 13 $236.40
86708 <1% 14 $187.30
87205 <1% 42 $176.68
83615 <1% 26 $166.80
99024 <1% 79 $135.54
87400 <1% 21 $130.58
84466 <1% 20 $123.34
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 47 $114.09
84481 <1% 17 $109.25
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 12 $89.15
82570 <1% 27 $88.93
86200 <1% 12 $87.18
36415 Collection of venous blood by venipuncture <1% 371 $82.25
94760 <1% 12 $68.90
83540 <1% 20 $64.12
84156 <1% 27 $62.28
86592 <1% 27 $61.42
0272 <1% 159 $29.77
87081 <1% 14 $27.33
80320 <1% 65 $11.29
80050 General health panel 0% 19 $0.00
80377 0% 18 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKAPRE, SHEELA (CHIEF MEDICAL OFFICER)
Same official

Other billing entities under KAPRE, SHEELA

Full network →
ProviderLocationPaid
County of San JoaquinFrench Camp, CA$48.27M
San Joaquin Faculty Medical GroupFrench Camp, CA$12.01M
County of San JoaquinFrench Camp, CA$11.04M
County of San JoaquinFrench Camp, CA$202K
County of San JoaquinFrench Camp, CA$3K
County of San JoaquinFrench Camp, CA$262.02

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.